The EPS projection of Colfax Corporation (NYSE:CFX) for quarter ended 2016-09-30 is $0.35. Last week, the EPS forecast was $0.35 against target of $0.35, a month earlier. Two months ago, this estimate was $0.35 versus forecast of $0.35 three months earlier, implying a deviation of 0%.
Colfax Corporation (NYSE:CFX) stated that 18 days ago, its stock price was positively revised 1 times while negative revisions were 2.
In last week, the experts lowered EPS 0 times and increased EPS 0 times. In last 30, 120, 60 and 90 days, the experts upped revisions 0 , 4, 2, and 4, correspondingly.
EPS estimate downgrade for Colfax Corporation (NYSE:CFX) in the preceding 30, 120, 60 and 90 days were 0, 3, 4, and 3, correspondingly.
Colfax Corporation (NYSE:CFX) EPS target for the quarter closed 1 was $0.35, based on 12 recommendations. As reported on 2016-05-03 the EPS was $0.3. The change was $0.03, implying a percentage deviation of 11.11%. The projections showed a standard deviation of 0.02.
Quarterly Sales Estimates
Colfax Corporation (NYSE:CFX) yearly sales prediction for the fiscal 2017 stands at $1046.75 and the median estimate is at $1046.75. Almost 2 analysts issued sales target.
Highest sales target is $1050 while the lowest target is $1043.5 showing standard deviation of 4.596%.
As many as 2 analysts have sales targets revised upside while 2 reduced sales estimates, implying a deviation of 0%.
Last month, 2 revised sales number projection on upside while 2 lowered the sales projections, implying a deviation of 0%.
A quarter ago, 2 hiked sales target and 2 reduced sales forecast. Colfax Corporation (NYSE:CFX) announced that the deviation in forecast was -0.767%.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...